Back to Search

KATHERINE NATHANSON, MD

MD

Clinical Genetics (M.D.) Physician

NPI: 1841226024IndividualAccepts Medicare

Specialties, Licenses & Credentials

Internal Medicine Physician

Internal Medicine

Code: 207R00000X

MD059456L(PA)
Pediatrics Physician

Pediatrics

Code: 208000000X

MD059456L(PA)
Clinical Genetics (M.D.) PhysicianPrimary

Medical Genetics — Clinical Genetics (M.D.)

Code: 207SG0201X

MD059456L(PA)

CMS Specialties

PrimaryPEDIATRIC MEDICINE

Education

PERELMAN SCHOOL OF MED AT THE UNIVERSITY OF PENNSYLVANIA

Class of 1993

Research & Publications (20)

The Y deletion gr/gr and susceptibility to testicular germ cell tumor.
PMID 16380914·Am J Hum Genet·2005
4-observational
Somatic genetic changes in association with testicular germ cell tumor prognosis.
PMID 15640621·Cancer Biol Ther·2004
8-other
CGH-targeted linkage analysis reveals a possible BRCA1 modifier locus on chromosome 5q.
PMID 12019214·Hum Mol Genet·2002
8-other
"Other" breast cancer susceptibility genes: searching for more holy grail.
PMID 11257104·Hum Mol Genet·2001
6-review
An intronic variant in PTEN is not associated with prostate cancer risk.
PMID 11303600·Cancer Epidemiol Biomarkers Prev·2001
4-observational
Breast cancer genetics: what we know and what we need.
PMID 11329055·Nat Med·2001
6-review
The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes.
PMID 19389934·Am J Pathol·2009
7-preclinical
Bilateral pneumothoraces, cystic lung disease and papular skin lesions in a young man.
PMID 19401486·Thorax·2009
5-case
Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer.
PMID 19483682·Nat Genet·2009
8-other
Active Notch1 confers a transformed phenotype to primary human melanocytes.
PMID 19549918·Cancer Res·2009
8-other
Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers.
PMID 19584272·Cancer Res·2009
4-observational
Younger age-at-diagnosis for familial malignant testicular germ cell tumor.
PMID 19609727·Fam Cancer·2009
4-observational
Expression of sorafenib targets in melanoma patients treated with carboplatin, paclitaxel and sorafenib.
PMID 19188183·Clin Cancer Res·2009
3-trial
Genetic subgrouping of melanoma reveals new opportunities for targeted therapy.
PMID 19351826·Cancer Res·2009
6-review
Malignant paraganglioma associated with succinate dehydrogenase subunit B in an 8-year-old child: the age of first screening?
PMID 19189136·Pediatr Nephrol·2009
5-case
Distinct patterns of DNA copy number alterations associate with BRAF mutations in melanomas and melanoma-derived cell lines.
PMID 19226609·Genes Chromosomes Cancer·2009
8-other
Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence.
PMID 19609668·Breast Cancer Res Treat·2009
3-trial
No evidence that GATA3 rs570613 SNP modifies breast cancer risk.
PMID 19082709·Breast Cancer Res Treat·2009
8-other
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.
PMID 19656774·Hum Mol Genet·2009
4-observational
CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations.
PMID 18794803·Oncogene·2009
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
3400 CIVIC CENTER BLVD, 2 EAST
PHILADELPHIA, PA 19104

Location

Practice Location

3400 CIVIC CENTER BLVD, PHILADELPHIA, PA
(215) 662-4740

Quick Facts

NPI
1841226024
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
3
Locations
1
Years in Practice
33
Publications
20

Are you this provider?

Claim Your Profile